HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyuki Fujii Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

1/2021Thrombomodulin promotes placental function by up-regulating placental growth factor via inhibition of high-mobility-group box 1 and hypoxia-inducible factor 1α.
1/2020The effects of tokishakuyakusan, a traditional Japanese medicine (kampo), ferulic acid and paeoniflorin, on human endometriotic stromal cells and peritoneal macrophages.
1/2017Activation of Endoplasmic Reticulum Stress in Granulosa Cells from Patients with Polycystic Ovary Syndrome Contributes to Ovarian Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyuki Fujii Research Topics

Disease

47Neoplasms (Cancer)
06/2021 - 01/2013
27Endometriosis
01/2021 - 01/2013
19Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 08/2012
15Inflammation (Inflammations)
01/2022 - 08/2011
15Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021 - 01/2012
13Pre-Eclampsia (Preeclampsia)
11/2021 - 11/2004
11Carcinoma (Carcinomatosis)
11/2020 - 05/2016
10Ovarian Neoplasms (Ovarian Cancer)
04/2020 - 03/2014
8Hypoxia (Hypoxemia)
11/2021 - 10/2004
7Infections
01/2022 - 01/2003
7Carcinogenesis
12/2020 - 01/2013
6Leiomyoma (Uterine Fibroids)
01/2022 - 02/2015
6Adenomyosis
01/2021 - 10/2014
6Hemorrhage
10/2020 - 05/2014
6Infertility (Sterility)
01/2020 - 05/2014
5Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
11/2021 - 05/2014
5Ascites
10/2020 - 01/2016
5Premature Birth (Birth, Premature)
08/2020 - 11/2013
4Body Weight (Weight, Body)
10/2020 - 04/2019
3Uterine Cervical Dysplasia
04/2021 - 02/2014
3Choriocarcinoma
02/2020 - 03/2009
3Dysmenorrhea (Menstrual Pain)
08/2018 - 10/2015
3Neoplasm Metastasis (Metastasis)
01/2018 - 01/2014
3Papillomavirus Infections
06/2016 - 01/2003
3Premature Obstetric Labor (Premature Labor)
06/2015 - 03/2013
2Hypertension (High Blood Pressure)
04/2022 - 05/2021
2Cysts
03/2022 - 09/2014
2Fistula
01/2021 - 02/2015
2Obesity
01/2021 - 01/2017
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2020 - 01/2012
2Pulmonary Embolism
10/2020 - 01/2013
2Anemia
10/2020 - 10/2014
2Uterine Hemorrhage (Uterine Bleeding)
10/2020 - 09/2020
2Pathologic Constriction (Stenosis)
02/2020 - 04/2016
2Autoimmune Diseases (Autoimmune Disease)
01/2020 - 10/2019
2Hyperandrogenism
01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2013
14CytokinesIBA
01/2022 - 01/2002
11Messenger RNA (mRNA)IBA
01/2021 - 03/2014
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 12/2005
8dienogestFDA Link
10/2020 - 09/2014
7Progestins (Progestagens)IBA
01/2020 - 03/2013
6Histone MethyltransferasesIBA
11/2021 - 06/2017
5Cisplatin (Platino)FDA LinkGeneric
06/2021 - 01/2013
5ProgesteroneFDA LinkGeneric
01/2021 - 03/2009
5Estradiol (Delestrogen)FDA LinkGeneric
08/2020 - 06/2018
5Small Interfering RNA (siRNA)IBA
04/2020 - 10/2016
5Biomarkers (Surrogate Marker)IBA
10/2019 - 03/2014
4Tyrosine (L-Tyrosine)FDA Link
11/2021 - 11/2004
4Histones (Histone)IBA
11/2021 - 01/2019
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2020 - 01/2016
4Therapeutic UsesIBA
08/2020 - 09/2014
4Estrogens (Estrogen)FDA Link
11/2018 - 10/2014
4ResveratrolIBA
10/2016 - 03/2014
3LigandsIBA
01/2021 - 11/2016
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2017
3LipopolysaccharidesIBA
01/2021 - 12/2015
3Sirtuin 1IBA
04/2020 - 08/2012
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
02/2020 - 03/2018
3EnzymesIBA
01/2020 - 10/2011
3DNA (Deoxyribonucleic Acid)IBA
12/2019 - 03/2014
3Hormones (Hormone)IBA
07/2019 - 10/2014
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 03/2014
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018 - 08/2015
3SurvivinIBA
11/2018 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 03/2014
3Oxygen (Dioxygen)IBA
01/2017 - 11/2004
3Antineoplastic Agents (Antineoplastics)IBA
06/2016 - 08/2015
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2014 - 01/2013
3VaccinesIBA
02/2013 - 01/2012
2Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
04/2022 - 04/2018
2Biological ProductsIBA
01/2022 - 01/2013
2Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 09/2014
2hydrogen sulfite (bisulfite)IBA
11/2021 - 02/2020
2AndrogensIBA
11/2021 - 01/2020
2LipidsIBA
06/2021 - 04/2017
2Bevacizumab (Avastin)FDA Link
06/2021 - 10/2017
2Pharmaceutical PreparationsIBA
06/2021 - 11/2020
2ThrombomodulinIBA
01/2021 - 01/2021
2Estrogen ReceptorsIBA
01/2021 - 11/2018
2AnticoagulantsIBA
01/2021 - 10/2020
2HMGB1 Protein (HMG1)IBA
01/2021 - 08/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2020 - 10/2019
2Hemoglobins (Hemoglobin)IBA
10/2020 - 08/2018
2Levonorgestrel (Plan B)FDA LinkGeneric
01/2020 - 10/2015
2InterferonsIBA
01/2020 - 02/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 06/2017
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 07/2016
2AntralIBA
11/2019 - 01/2019

Therapy/Procedure

20Therapeutics
10/2020 - 01/2013
10Hysterectomy
10/2020 - 07/2014
9Drug Therapy (Chemotherapy)
06/2021 - 01/2013
4Cesarean Section (Caesarean Section)
01/2021 - 02/2017
4Immunotherapy
10/2019 - 02/2014
4Uterine Myomectomy
10/2018 - 09/2014
2Oral Administration
04/2021 - 09/2020
2Catheters
01/2021 - 12/2006
2Blood Transfusion (Blood Transfusions)
10/2020 - 05/2014
2Molecular Targeted Therapy
10/2020 - 12/2019
2Radiotherapy
12/2019 - 07/2015